CL
TEVA icon

CSS LLC’s Teva Pharmaceuticals TEVA Stock Holding History

CSS LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Hold
27,070
– – 0.04% 375
2026
Q1 		$815K Hold
27,070
– – 0.04% 396
2025
Q4 		$845K Sell
27,070
-7,480
-22% -$184K 0.04% 372
2025
Q3 		$698K Buy
+34,550
New +$607K 0.03% 428
2025
Q2 		– Sell
-27,100
Closed -$417K – 1139
2025
Q1 		$417K Buy
+27,100
New +$484K 0.02% 542
2020
Q1 		– Sell
-3,039
Closed -$30K – 752
2019
Q4 		$30K Sell
3,039
-12,500
-80% -$112K ﹤0.01% 611
2019
Q3 		$107K Buy
15,539
+7,500
+93% +$57.5K 0.01% 499
2019
Q2 		$74K Buy
+8,039
New +$96.9K ﹤0.01% 649
2019
Q1 		– Sell
-25,000
Closed -$441K – 579
2018
Q4 		$386K Buy
+25,000
New +$513K 0.03% 318

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

CSS LLC's TEVA Position: Q2 2026 in Review

CSS LLC held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 27,070 shares worth $917K. The position accounts for 0.04% of the portfolio, ranked #375.

CSS LLC first reported a position in TEVA in Q4 2018 and has held it in 9 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • CSS LLC held 27,070 shares of Teva Pharmaceuticals worth $917K as of Q2 2026.
  • CSS LLC left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.04% of CSS LLC's portfolio in Q2 2026, its #375 holding.
  • CSS LLC first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 9 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.